COVID-19 and Cancer: Addressing a Healthcare System in Crisis

Attend ASCO Presscast for New Data, Insights, and a View from the Front Lines Thursday, April 23, 2020 at 3:00 p.m. ET
For immediate release
April 22, 2020

Contact

Melissa Lee
(571) 483-1661

WHAT: The U.S. cancer care delivery system is facing unprecedented challenges during the COVID-19 pandemic. Cancer care teams and the patients they serve are navigating significant barriers to high-quality care and impossibly difficult choices regarding allocation of potentially life-saving medical resources to critically ill patients. Across the country, in all settings of care, providers and patients are dealing with social distancing; scarce protective equipment; treatment interruptions or alterations; a near-overnight shift to telehealth; halted clinical trials denying some patients access to their best treatment option; reduced or eliminated incomes due to stay-at-home orders; and COVID-19-positive diagnoses in providers, patients and caregivers. Further, in many communities, cancer screenings and some surgeries have been postponed until the pandemic subsides-a situation that could have long-term negative consequences.

The ASCO presscast will feature a panel of experts focusing on the COVID-19 pandemic's impact on the cancer care delivery system, the response by federal agencies, and steps the cancer care community has taken to mitigate the impact of coronavirus. The panel will provide the very latest on this evolving situation and an announcement of ASCO's recommendations to the Administration and Congress.

WHO:

  • Howard A. "Skip" Burris, MD, FACP, FASCO; ASCO President; Chief Medical Officer and Executive Director, Sarah Cannon Research Institute (Nashville, TN)
  • Anand Shah, MD, FDA Deputy Commissioner for Medical and Scientific Affairs (Silver Spring, MD)
  • Richard L. Schilsky, MD, FACP, FSCT, FASCO; ASCO Chief Medical Officer and Executive Vice President (Alexandria, VA)
  • Melissa Dillmon, MD, FASCO; Chair, ASCO Government Relations Committee; Hematologist/Oncologist, Harbin Clinic Cancer Center (Rome, GA)
  • Jonathan Marron, MD, MPH, FAAP; Chair-Elect, ASCO Ethics Committee; Attending Physician, Pediatric Hematology/Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center (Boston, MA)
  • Dr. Gary Lyman, MD, MPH, FASCO, FACP, FRCP; Senior Lead, Hutchinson Institute for Cancer Outcomes Research (Seattle, WA)

WHEN: Thursday, April 23, 2020; 3:00 p.m. - 4:00 p.m. ET

WHERE: Register for this online event now.

Questions: Please contact Melissa Lee at Melissa.Lee@asco.org or 571-483-1661.

About ASCO: 

Founded in 1964, the American Society of Clinical Oncology, Inc. (ASCO®) is committed to making a world of difference in cancer care. As the world’s leading organization of its kind, ASCO represents nearly 45,000 oncology professionals who care for people living with cancer. Through research, education, and promotion of the highest-quality patient care, ASCO works to conquer cancer and create a world where cancer is prevented or cured, and every survivor is healthy. ASCO is supported by its affiliate organization, the Conquer Cancer Foundation. Learn more at www.ASCO.org, explore patient education resources at www.Cancer.Net, and follow us on Facebook, Twitter, LinkedIn, and YouTube.